102 related articles for article (PubMed ID: 8498976)
1. [Clinical findings with inhibitors of the renin-angiotensin system].
Dietz R; Süsselbeck T; Osterziel KJ
Arzneimittelforschung; 1993 Feb; 43(2A):265-70. PubMed ID: 8498976
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of inhibitors of the renin-angiotensin system.
Fouad-Tarazi FM
J Hypertens Suppl; 1994 Jul; 12(2):S25-9. PubMed ID: 7965262
[TBL] [Abstract][Full Text] [Related]
4. [The significance of converting enzyme inhibitor angiotensin I to angiotensin II in treatment of patients with coronary disease].
Halawa B
Pol Merkur Lekarski; 1998 Jan; 4(19):32-4. PubMed ID: 9553407
[TBL] [Abstract][Full Text] [Related]
5. Effect of ACE inhibition on myocardial ischaemia.
Ferrari R
Eur Heart J; 1998 Sep; 19 Suppl J():J30-5. PubMed ID: 9796838
[TBL] [Abstract][Full Text] [Related]
6. Interactions between the renin-angiotensin system and the parasympathetic nervous system in heart failure.
Osterziel KJ; Hänlein D; Dietz R
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S70-4. PubMed ID: 7898098
[TBL] [Abstract][Full Text] [Related]
7. Blocking the renin-angiotensin system: dual- versus mono-therapy.
Ravandi A; Teo KK
Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):667-74. PubMed ID: 19505282
[TBL] [Abstract][Full Text] [Related]
8. Dissociation between ACE activity and autonomic response to ACE inhibition in patients with heart failure.
Binkley PF; Nunziata E; Haas GJ; Starling RC; Leier CV; Cody RJ
Am Heart J; 2000 Jul; 140(1):34-42. PubMed ID: 10874261
[TBL] [Abstract][Full Text] [Related]
9. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
10. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
11. The tissue renin-angiotensin system: a target for angiotensin-converting enzyme inhibitors.
Ganten D; Mullins J; Lindpaintner K
J Hum Hypertens; 1989 Jun; 3 Suppl 1():63-70. PubMed ID: 2674443
[TBL] [Abstract][Full Text] [Related]
12. Effect of high salt intake on local renin-angiotensin system and ventricular dysfunction following myocardial infarction in rats.
de Resende MM; Mill JG
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):274-9. PubMed ID: 17324137
[TBL] [Abstract][Full Text] [Related]
13. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of the renin-angiotensin system.
Brunner HR; Nussberger J; Waeber B
Arzneimittelforschung; 1993 Feb; 43(2A):274-8. PubMed ID: 8498978
[TBL] [Abstract][Full Text] [Related]
18. [Pathophysiological and clinical implications of AT(1)/AT(2) angiotensin II receptors in heart failure and coronary and renal failure].
Sandmann S; Unger T
Drugs; 2002; 62 Spec No 1():43-52. PubMed ID: 12036388
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.
Hollenberg NK
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S239-42. PubMed ID: 9892171
[TBL] [Abstract][Full Text] [Related]
20. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
Dzau VJ
Circulation; 1988 Jun; 77(6 Pt 2):I4-13. PubMed ID: 3286045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
